Overcoming challenging targets in antibody discovery
Webinar Overview: Unlock solutions for your most challenging targets with this webinar that demonstrates how Alloy Therapeutic’s precision approach to antibody discovery delivers results. This technical discussion explores: The power of hyperimmune mice: Benefit from ATX-GKH’s enhanced immune responses that produce higher serum titers and increased lymphoid cell output, especially valuable for high homology Streamline […]
Identify functional chimeric antigen receptors three months faster with Alloy’s end-to-end CAR discovery
Webinar overview: Looking for a way to accelerate your CAR-T therapeutic development projects? This presentation highlights how Alloy’s comprehensive platform and expertise can enable you to: Streamline end-to-end CAR discovery: Learn how Alloy’s full stack technologies enable discovery and screening of functional CARs with unprecedented speed and cost efficiency, overcoming limitations of conventional two-step processes. […]
Discover TCR mimic antibodies that Target Previously “Undruggable” Intracellular Proteins with Keyway™ TCR
Webinar Overview: Unlock access to intracellular protein targets and maximize TCRm/TCR-based therapeutic antibody discovery with this presentation by Dr. Dongxing Zha that reveals how Alloy’s proprietary Keyway™ TCRm Discovery Platform and expertise can: Overcome challenges to intracellular protein-targeted drug discovery: Learn how the Keyway™ TCRm Discovery Platform identifies TCR mimic (TCRm) antibodies that target intracellular […]
Accelerating Bispecific Discovery with the Alloy Common Light Chain Platform
Webinar Overview Discover the full potential of bispecific antibody therapeutics and how to accelerate their discovery during this presentation by Dr. Lucy Liu that reveals how Alloy’s technologies, services, and expertise is able to: Accelerate bispecific antibody discovery: Learn how the Alloy Common Light Chain (CLC) human, transgenic platform streamlines bispecific antibody discovery and development, […]
Accelerating Therapeutic Discovery: ATX-Gx™ Human, Transgenic Platform
Webinar Overview Ready to dramatically accelerate your therapeutic antibody discovery pipeline? In this presentation, Dr. John “Lippy” Lippincott shares how our ATX-Gx™ human, transgenic mouse platform can help: Accelerate antibody discovery: Learn how this platform, used by 100’s of biotechs and large pharma, can significantly speed up the identification of therapeutic antibody candidates against diverse […]
Discovering Antibodies in Months
Access the webinar recording Thanks for your interest in our recent antibody discovery webinar, Discovering Antibodies in Months: New Advances in HT-SPR, Single-Cell BCR-Seq and RNA-Seq. Alloy Head of Global Bioanalytics Dr. Lucy Liu presented on our workflow that improve the speed and quality of the antibody discovery process. Please fill out your contact information, and […]
Fully Human Antibody Discovery Using Nanovials and Plasma Cells From ATX-GK™ Mice
Webinar Overview: Discover how to access previously untapped sources of high-affinity antibodies. In this presentation, Dr. Joe de Rutte from Partillion Bioscience and Dr. Dilip Challa from Alloy Therapeutics discuss how breakthrough technology can help: Access Plasma Cell Diversity: Discover how nanovial technology enables screening of plasma cells from ATX-GK transgenic mice harboring fully human […]